Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Mont...(TRIPLA(TM) is a trademark of both Bristo...),Health

Erbitux(R) is a trademark of ImClone Systems Incorporated

BRISTOL-MYERS SQUIBB COMPANY

NET SALES FROM CONTINUING OPERATIONS BY OPERATING SEGMENT

FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2007 AND 2006

(Unaudited, dollars in millions)

Three Months Twelve Months

Ended December 31, Ended December 31,

2007 2006 2007 2006

Pharmaceuticals $4,388 $3,148 $15,622 $13,861

Nutritionals 670 618 2,571 2,347

ConvaTec 323 291 1,155 1,048

Health Care Group 993 909 3,726 3,395

Net Sales from continuing

operations $5,381 $4,057 $19,348 $17,256

BRISTOL-MYERS SQUIBB COMPANY

SELECTED PRODUCTS

FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2007 AND 2006

(Unaudited, dollars in millions)

The following table sets forth worldwide and U.S. reported net sales for selected products for the three and twelve months ended December 31, 2007 compared to the three and twelve months ended December 31, 2006. In addition, the table includes, where applicable, the estimated total U.S. prescription change for the retail and mail-order channels for the comparative periods presented for certain of the company's U.S. pharmaceutical products based on third-party data. A significant portion of the company's U.S. pharmaceutical sales is made to wholesalers. Where changes in reported net sales
'/>"/>